Rajkumar Banerjee

This inventor holds 9 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2001-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajkumar Banerjee. Retrieved from https://idiyas.com/inventor/rajkumar-banerjee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 146(Granted Patents)

Location History:

Andhra Pradesh, IN (2011 - 2016)
Hyderabad, IN (2001 - 2018)
Hederabad, IN (2018)

Company Filing History:

9 out of 2,130

Council of Scientific and Industrial Research

patents

Years Active: 2001-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10100079 - Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof (2018-10-16),

2. 9861653 - Synergistic anti-cancer composition and a process for the preparation thereof (2018-01-09),

3. 9763881 - Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells (2017-09-19),

4. 9364566 - Aqueous formulation for selective targeting and delivering gene to cancer cells (2016-06-14),

5. 8012952 - Cationic 17 α-substituted-estradiol derivatives useful as anti-cancer agent (2011-09-06),

6. 6541649 - Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules (2003-04-01),

7. 6503945 - Cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules (2003-01-07),

8. 6346516 - Cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules (2002-02-12),

9. 6333433 - Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkl group for intracellular delivery of biologically active molecules (2001-12-25),

Title: Rajkumar Banerjee: Innovator in Anti-Cancer Therapeutics

Introduction

Rajkumar Banerjee is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of anti-cancer therapeutics, holding a total of 9 patents. His work focuses on developing innovative solutions to combat aggressive forms of cancer, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest patents is the invention titled "Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof." This invention relates to the development of cationic progesterone compounds as novel anti-tumor agents. It provides a method for preparing a series of progesterone derivatives that exhibit highly selective anti-cancer activities across a wide range of cancer cells, regardless of their progesterone receptor status. The disclosed cationic progesterone compounds present a promising option for anti-cancer therapeutics.

Another significant patent is "Synergistic anti-cancer composition and a process for the preparation thereof." This invention offers a lipid-based anti-cancer composition that effectively targets aggressive pancreatic cancer cells and breast cancer stem cell-like cells. The composition combines an anti-cancer agent, ESC8, with a glucocorticoid receptor-targeting cationic lipid delivery system, DX, complexed with plasmid DNA. Remarkably, this formulation initiates the killing of cancer cells within three hours, demonstrating a significant advantage over traditional treatments.

Career Highlights

Rajkumar Banerjee has worked with esteemed organizations such as the Council of Scientific and Industrial Research and the Mayo Foundation for Medical Education and Research. His experience in these institutions has contributed to his expertise in cancer research and therapeutic development.

Collaborations

Throughout his career, Rajkumar has collaborated with notable colleagues, including Prasanta Kumar Das and Gollapudi Venkata Srilakshmi. These collaborations have further enriched his research and innovation in the field of anti-cancer therapies.

Conclusion

Rajkumar Banerjee stands out as a dedicated inventor whose work in anti-cancer therapeutics has the potential to make a significant impact on cancer treatment. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.